Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Irina N. Alimova"'
Autor:
Olga G. Kvasova, Yuliya A. Tomashevskaya, Irina N. Alimova, Ekaterina A. Klimova, Elena A. Sadovnikova
Publikováno v:
Известия высших учебных заведений. Поволжский регион: Медицинские науки, Iss 1 (2024)
Background. Tuberous sclerosis (TS) is a genetically determined disease with an autosomal dominant type of inheritance. In the population, TS occurs with a frequency of 1:10000 (in newborns 1:6000). The disease is characterized by a variety of clinic
Externí odkaz:
https://doaj.org/article/aa41174fbfb24e4582dec55af0a77eee
Although the role of the classic retinoic acid (RA)-induced genomic pathway in cancer cell differentiation is well recognized, the underlying mechanisms remain to be dissected. Retinoic acid receptor alpha (RARalpha) is a transcription factor activat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92bc3f02dc7259993331ca9dc366450f
https://europepmc.org/articles/PMC2830139/
https://europepmc.org/articles/PMC2830139/
Autor:
Vladimir N, Anisimov, Vladimir Kh, Khavinson, Irina G, Popovich, Mark A, Zabezhinski, Irina N, Alimova, Svetlana V, Rosenfeld, Natalia Yu, Zavarzina, Anna V, Semenchenko, Anatoli I, Yashin
Publikováno v:
Biogerontology. 4(4)
From the age of 3 months until their natural deaths, female outbred Swiss-derived SHR mice were subcutaneously injected on 5 consecutive days every month with 0.1 ml of normal saline (control) or with 1.0 microg/mouse (approximately 30-40 microg/kg)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f29e09131ecfb6f02e319bd656f76562
https://pubmed.ncbi.nlm.nih.gov/14501183
https://pubmed.ncbi.nlm.nih.gov/14501183
Autor:
Vladimir N, Anisimov, Vladimir K H, Khavinson, Mauro, Provinciali, Irina N, Alimova, Dmitri A, Baturin, Irina G, Popovich, Mark A, Zabezhinski, Eugeni N, Imyanitov, Romina, Mancini, Claudio, Franceschi
Publikováno v:
International journal of cancer. 101(1)
Female FVB/N HER-2/neu transgenic mice from the age of 2 months were subcutaneously injected with saline, the peptide Epitalon(R) (Ala-Glu-Asp-Gly) or with the peptide Vilon(R) (Lys-Glu) in a single dose of 1 microg/mouse for 5 consecutive days every
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3a0eb7887f0a7d07fa7c8b7489e0cf8
https://pubmed.ncbi.nlm.nih.gov/12209581
https://pubmed.ncbi.nlm.nih.gov/12209581